3.485
前日終値:
$3.86
開ける:
$3.75
24時間の取引高:
3.70M
Relative Volume:
0.45
時価総額:
$1.04B
収益:
$6.23M
当期純損益:
$-95.90M
株価収益率:
-8.9359
EPS:
-0.39
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
-7.90%
1か月 パフォーマンス:
-12.06%
6か月 パフォーマンス:
+104.67%
1年 パフォーマンス:
+278.94%
Precigen Inc Stock (PGEN) Company Profile
名前
Precigen Inc
セクター
電話
301-556-9900
住所
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
PGEN
Precigen Inc
|
3.495 | 1.36B | 6.23M | -95.90M | -68.47M | -0.39 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
381.48 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
449.22 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.46 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
710.39 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
329.13 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-15 | アップグレード | JP Morgan | Underweight → Neutral |
2024-03-22 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-05-23 | 開始されました | JP Morgan | Neutral |
2022-11-18 | 開始されました | Cantor Fitzgerald | Overweight |
2021-02-25 | 開始されました | Stifel | Buy |
2021-02-22 | 開始されました | Wells Fargo | Overweight |
2021-02-18 | 開始されました | B. Riley Securities | Buy |
2020-05-08 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Precigen Inc (PGEN) 最新ニュース
Precigen (NASDAQ:PGEN) Trading Down 6.1%Time to Sell? - MarketBeat
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance
The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 3,596,892 Shares of Stock - MarketBeat
Precigen (PGEN) Is Up 7.2% After Securing $125M Credit For PAPZIMEOS Commercialization Plans Has The Bull Case Changed? - simplywall.st
Precigen (NASDAQ:PGEN) Director Randal J. Kirk Sells 1,403,360 Shares - MarketBeat
Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance
Precigen Bets On Gene Therapies After First FDA Approval - Finimize
Precigen (NASDAQ:PGEN) Stock Price Up 5.2%Time to Buy? - MarketBeat
Death Cross: How does Coherent Corp correlate with NasdaqJuly 2025 Breakouts & Real-Time Volume Spike Alerts - khodrobank.com
Inspire Investing LLC Makes New Investment in Precigen, Inc. $PGEN - MarketBeat
Growth Review: What are Precigen Incs growth levers2025 EndofYear Setup & Growth Focused Investment Plans - khodrobank.com
Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization - Yahoo Finance
Investment Review: Can Precigen Inc beat the S P 5002025 EndofYear Setup & Free Community Consensus Stock Picks - خودرو بانک
Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Precigen (NASDAQ:PGEN) Stock Price Down 3.7%What's Next? - MarketBeat
Precigen converts preferred stock into 54.9 million common shares By Investing.com - Investing.com Nigeria
Precigen Converts Preferred Stock to Common Shares - TipRanks
Precigen converts preferred stock into 54.9 million common shares - Investing.com India
Pullback Watch: Can Precigen Inc scale operations efficiently2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک
Movement Recap: Is Precigen Inc a play on infrastructure spendingRate Hike & Risk Managed Investment Signals - خودرو بانک
Analyst Downgrade: Is Precigen Inc stock a top performer YTDTrade Ideas & Expert Approved Momentum Ideas - خودرو بانک
Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - MSN
Growth Value: Is Precigen Inc. exposed to political riskJuly 2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - خودرو بانک
Is Precigen Stock Ready For Takeoff? - StocksToTrade
Resistance Check: Will Precigen Inc stock go up in YEARWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Ideas Watch: Will Precigen Inc stock go up in YEAREarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک
Precigen announces up to $125M non-dilutive financing - MSN
Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance
MetLife Investment Management LLC Purchases New Position in Precigen, Inc. $PGEN - MarketBeat
Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade
Could Precigen's (PGEN) New Credit Facility Reshape Its Approach to Shareholder Dilution? - simplywall.st
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN
4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next - PharmaVoice
EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS - Eastern Progress
Precigen Inc (PGEN) 財務データ
収益
当期純利益
現金流量
EPS
Precigen Inc (PGEN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
KIRK RANDAL J | Director |
Sep 18 '25 |
Sale |
3.86 |
1,403,360 |
5,416,970 |
12,117,429 |
大文字化:
|
ボリューム (24 時間):